Number of the records: 1  

Imunopatogenéza a imunoterapia Crohnovej choroby

  1. SYSr040735
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130619105512.9
    100
      
    $a 20070320a2006 m y0sloc0103 ba
    101
    0-
    $a slo $d eng $d slo
    102
      
    $a SK
    200
    1-
    $a Imunopatogenéza a imunoterapia Crohnovej choroby $d CrohnEs disease - current status of its immunopathogenesis and immunotherapy $e venované životnému jubileu prof. MUDr. Ivana Hruškoviča, CSc. $f M. Buc, M. Bucová $z eng
    215
      
    $c obr., tab.
    320
      
    $a Res. angl., slov.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000002_2006_006_003 $1 011 $a 1335-0838 $1 200 1 $a Detský lekár $v Zv. 13, č. 3 (2006), s. 26-28 a 30 $1 210 $a Bratislava $c BONUS
    510
    1-
    $a CrohnEs disease - current status of its immunopathogenesis and immunotherapy $z eng
    606
    1-
    $a Crohnova choroba $x farmakoterapia $x imunológia $x patológia $2 mesh $3 sllk_un_auth*d003424 $9 .
    606
    1-
    $a imunoterapia $2 mesh $3 sllk_un_auth*d007167 $9 .
    606
    1-
    $a choroby čreva, zápalové $x imunológia $2 mesh $3 sllk_un_auth*d015212 $9 .
    606
    2-
    $a T-lymfocyty $2 mesh $3 sllk_un_auth*d013601 $9 .
    606
    2-
    $a Smad7 proteín $2 mesh $3 sllk_un_auth*d051906 $9 .
    606
    2-
    $3 sllk_un_auth*d015398 $a transdukcia signálna $9 . $2 mesh
    606
    2-
    $a proteín signálny adaptorový, Nod2 $2 mesh $3 sllk_un_auth*d053473 $9 .
    610
    2-
    $a infliximab
    610
    2-
    $a natalizumab
    610
    2-
    $a TGF-beta
    610
    2-
    $a TLR2
    675
      
    $a 616.34-002-097 $v 2. $z slo
    700
    -1
    $a Buc $b Milan $f 1944- $3 sllk_un_auth*p0002253 $4 070 $p Ústav lekárskej imunológie LF UK, Bratislava
    701
    -1
    $a Bucová $b Mária $3 sllk_un_auth*p0023000 $4 070 $p Imunologický ústav LF UK, Bratislava
    801
    -0
    $a SK $b BA006 $c 20070320 $g AACR2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.